Unlike the mixed roles of CLOCK and BMAL1 in CSCs, period circadian regulator genes (e.g., PER2 and PER3), generally known as tumor suppressors in various types of cancer, have been shown to inhibit CSC maintenance and survival in tumors. This evidence concerns the gene PER2 and cancer.